2 weeks ago

Aurobindo's Eugia Pharma Telangana Unit Gets USFDA Warning Letter

Aurobindo's Eugia Pharma Telangana Unit Gets USFDA Warning Letter
Aurobindo’s Eugia Pharma Telangana unit gets warning letter from USFDA · thehansindia.com

A big medicine company called Aurobindo Pharma has a factory in Telangana, India, where it makes medicines.

Scientists from the United States government, called the FDA, visited the factory to check that everything is safe.

They looked around the factory for almost two weeks.

After the visit, they found four problems that need to be fixed.

Because of these problems, the FDA sent the company a serious letter called a warning letter.

This letter says the factory must fix the problems.

Aurobindo says the letter will not affect the medicines that people get in America.

The factory will keep sending medicines to the US as before.

The company will now work on making the FDA happy again.

Key facts

Company
Aurobindo Pharma
Affected subsidiary
Eugia Pharma Specialities Ltd
Facility
Unit-I formulation manufacturing facility
Location
Telangana, India
Inspection period
February 16-27, 2026
Inspection observations
4
Regulator designation
Official Action Indicated (OAI)
Impact on US supplies
No impact, according to the company

Sources

Related news